drugset
drugset / Trial / NCT03643575

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.

NCT03643575 ↗

Phase 1 Completed 30 enrolled Reckitt Benckiser Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

Characterize the relative pharmacokinetics (PK) of 3 marketed products containing guaifenesin

Timeline

Start
2009-06-30
Primary completion
2009-07-16
Completion
2009-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaifenesin Small molecule 200 mg —

Indications

No indication recorded.